Tissue healing via increased blood flow and oxygenation

This phrase describes a biological process or therapeutic outcome rather than a discrete drug target. It refers to the general physiological process by which tissues repair themselves when oxygen availability and perfusion improve. The search results demonstrate that this outcome is achieved through modulation of multiple underlying molecular targets and biological processes. The actual molecular targets involved in achieving this outcome include Vascular endothelial growth factor (VEGF), Angiopoietin, Fibroblast growth factor (FGF), Epidermal growth factor (EGF), Endothelial cells, and Endothelial progenitor cells (EPCs). Therefore, it is not a specific target, receptor, or therapeutic entity that can be structured in the requested format for a singular molecular entity.

Other names

Angiogenesis and revascularizationImproved tissue perfusionWound healing through oxygen supplyPro-angiogenic therapy outcome

This phrase describes a broad biological process or a desired therapeutic outcome rather than a molecular target with a specific mechanism of action. It is achieved by various molecular and cellular interventions that promote angiogenesis (new blood vessel formation) and improve blood flow, thereby increasing oxygen and nutrient delivery to damaged or ischemic tissues.